LIN-9 Activators
LIN-9 Activators encompass a collection of chemical compounds that indirectly stimulate the functional activity of LIN-9 through distinct signaling pathways and cellular mechanisms. Forskolin, by increasing intracellular cAMP, activates protein kinase A (PKA) which may phosphorylate proteins that regulate LIN-9, enhancing its role in cell cycle and transcriptional regulation. Similarly, ionomycin and A23187, as calcium ionophores, raise intracellular calcium levels, potentially activating pathways that could augment LIN-9's functionsin gene transcription and cell cycle regulation. PMA, through activation of protein kinase C (PKC), and Okadaic acid by inhibiting protein phosphatases, could both lead to modifications in the phosphorylation state of proteins that interact with LIN-9, potentially amplifying LIN-9's involvement in cell proliferation and differentiation. Additionally, chemical inhibitors like SB 202190, U0126, PD 98059, and LY294002 disrupt various MAP kinase and PI3K/Akt pathways, which may relieve inhibitory controls or redirect cellular signaling towards processes that enhance LIN-9's activity in the governance of cell cycle checkpoints and chromatin organization.
Trichostatin A (TSA), with its HDAC inhibitory activity, modifies chromatin accessibility and gene expression, possibly leading to increased LIN-9-mediated transcription crucial for cell division and development. ZM 447439, an Aurora kinase inhibitor, may influence mitotic spindle assembly and checkpoint controls, thereby potentially bolstering LIN-9's role in chromosomal segregation during cell division. Meanwhile, Sanguinarine's inhibition of NF-κB signaling could shift cellular regulatory networks in favor of pathways that promote LIN-9's activity, especially in aspects of cell proliferation and transcriptional control. Collectively, these LIN-9 Activators, through their targeted influence on cellular signaling and gene expression, facilitate the enhancement of LIN-9's roles, underpinning its critical functions without necessitating upregulation at the transcriptional or translational levels.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin directly stimulates adenylyl cyclase, leading to an increase in cyclic AMP (cAMP) levels. Elevated cAMP activates PKA, which may phosphorylate LIN-9, thus potentially enhancing its activity in cell cycle progression and transcriptional regulation. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Ionomycin acts as a calcium ionophore, elevating intracellular Ca²⁺ levels and possibly activating Ca²⁺/calmodulin-dependent pathways. Increased Ca²⁺ may enhance LIN-9 activity indirectly by stimulating pathways that interact with LIN-9's role in cell cycle control and gene expression. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA activates protein kinase C (PKC) which is involved in multiple signaling cascades. PKC can phosphorylate targets that may include regulators of LIN-9, thereby enhancing LIN-9's activity in promoting cell proliferation and differentiation. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
SB 202190 is a specific inhibitor of p38 MAP kinase. By inhibiting p38, it may shift the balance of cellular signaling pathways, leading to an indirect enhancement of LIN-9 activity by promoting pathways that favor LIN-9's role in the cell cycle. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 is a PI3K inhibitor that, by blocking PI3K/Akt pathway, may indirectly enhance LIN-9 activity through the modulation of pathways that intersect with LIN-9's role in cell cycle and chromatin organization. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
PD 98059 is an inhibitor of MEK, which acts upstream of ERK in the MAPK pathway. Inhibition of this pathway can alter the cellular signaling context, potentially enhancing LIN-9's activity in regulating progression through the cell cycle. | ||||||
A23187 | 52665-69-7 | sc-3591 sc-3591B sc-3591A sc-3591C | 1 mg 5 mg 10 mg 25 mg | $55.00 $131.00 $203.00 $317.00 | 23 | |
A23187 acts as a calcium ionophore, similarly to Ionomycin. By increasing intracellular calcium, it can activate downstream pathways that might enhance the function of LIN-9 in processes such as gene transcription and cell cycle regulation. | ||||||
Okadaic Acid | 78111-17-8 | sc-3513 sc-3513A sc-3513B | 25 µg 100 µg 1 mg | $291.00 $530.00 $1800.00 | 78 | |
Okadaic acid is a potent inhibitor of protein phosphatases 1 and 2A. Inhibition of these phosphatases could lead to an increase in the phosphorylated state of proteins that regulate LIN-9 activity, thereby enhancing LIN-9's role in the cell cycle and gene expression. | ||||||
Sanguinarium | 2447-54-3 | sc-473396 | 10 mg | $220.00 | ||
Sanguinarium can inhibit NF-κB activation. By modulating this pathway, it could shift the equilibrium towards signaling pathways that enhance LIN-9 activity, particularly in the context of cell proliferation and transcriptional regulation. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
TSA is an inhibitor of histone deacetylases (HDACs). By altering chromatin structure and gene expression, TSA could enhance LIN-9-mediated transcriptional programs essential for cell cycle progression and development. | ||||||